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Abstract
Background: Diarrheal diseases continue to contribute significantly to morbidity and mortality in infants and
young children in developing countries. There is an urgent need to better understand the contributions of novel,
potentially uncultured, diarrheal pathogens to severe diarrheal disease, as well as distortions in normal gut
microbiota composition that might facilitate severe disease.
Results: We use high throughput 16S rRNA gene sequencing to compare fecal microbiota composition in children
under five years of age who have been diagnosed with moderate to severe diarrhea (MSD) with the microbiota
from diarrhea-free controls. Our study includes 992 children from four low-income countries in West and East Africa,
and Southeast Asia. Known pathogens, as well as bacteria currently not considered as important diarrhea-causing
pathogens, are positively associated with MSD, and these include Escherichia/Shigella, and Granulicatella species, and
Streptococcus mitis/pneumoniae groups. In both cases and controls, there tend to be distinct negative correlations
between facultative anaerobic lineages and obligate anaerobic lineages. Overall genus-level microbiota composition
exhibit a shift in controls from low to high levels of Prevotella and in MSD cases from high to low levels of
Escherichia/Shigella in younger versus older children; however, there was significant variation among many genera
by both site and age.
Conclusions: Our findings expand the current understanding of microbiota-associated diarrhea pathogenicity in
young children from developing countries. Our findings are necessarily based on correlative analyses and must be
further validated through epidemiological and molecular techniques.
Background
Diarrheal diseases continue to be major causes of child-
hood mortality, ranking among the top four largest con-
tributors to years of life lost in sub-Saharan Africa and
South Asia [1]. The proportion of deaths attributed to
diarrhea among children aged under 5 years is estimated
to be approximately 15% worldwide [2], and as high as
approximately 25% in Africa and 31% in South East Asia
[3]. More than two dozen enteric pathogens, belonging
to diverse branches of the tree of life, are known to
cause diarrhea and can be tested for in a clinical setting.
However, it is likely that additional pathogens remain to
be identified among the enteric microbiota.
In response to important unanswered questions sur-
rounding the burden and etiology of childhood diarrhea
in developing countries, the William and Melinda Gates
Foundation commissioned the Global Enterics Multicen-
ter Study (GEMS) [4], which recently reported the patho-
gens responsible for cases of moderate-to-severe diarrhea
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(MSD) in seven impoverished countries of sub-Saharan
Africa and south Asia. Importantly, for approximately 60%
of MSD cases in GEMS, no known pathogen could be im-
plicated by conventional diagnostic methods [5]. These
observations highlight the potential presence of previously
undiscovered pathogens, and/or possible interactions be-
tween pathogens and other members of the intestinal
microbiota (both pathogenic and commensal) that may ei-
ther exacerbate the clinical manifestation or protect the
host from disease.
Here we apply molecular techniques to survey the intes-
tinal microbiota in a subset of GEMS cases and controls.
Our study comprises 992 children from four under-
developed countries in West Africa (The Gambia and
Mali), East Africa (Kenya), and South Asia (Bangladesh),
representing a subset of the over 25,000 GEMS children
enrolled. Our results shed additional light on potential
mechanisms underlying MSD in children of developing
countries. Prior to presenting these results we would like
to stress that our analyses are, by necessity, correlative
and the results presented here must be validated through
epidemiological and molecular analyses, several of which
are already underway.
Results and discussion
Description of data
Our data comprise roughly equal proportions of cases
and controls (0.51 vs. 0.49, respectively) from four sites:
Bangladesh (N = 206), The Gambia (N = 269), Kenya (N =
305), and Mali (N = 212). Approximately 55% of the sub-
jects were boys. Of 992 samples, 508 were from patients
with MSD (Table 1). The children ranged in age from
newborn to 59 months. We stratified them into five age
categories: 0 to 5 months (N = 112), 6 to 11 months (N =
308), 12 to 17 months (N = 173), 18 to 23 months (N =
146), and 24 to 59 months (N = 253). There were no
significant differences between the proportion of cases
and controls in each country and from each age group
(Table 1). The sequencing of PCR amplified 16S rRNA
genes resulted in 3,584,096 reads passing quality checks.
Each sample had at least 1,000 reads, and there were an
average of 3,613 reads per sample. The reads were clus-
tered using DNAclust [6] into 97,666 operational taxo-
nomic units (OTUs). Of these, 21,247 passed chimera
checking, were detected in more than five samples, or rep-
resented at least 20 sequences in a single sample, and were
included in further analysis. The number of OTUs per
sample ranged from 55 to 1252, with a median of 380 and
an average of 412. The mean OTU size was 138, ranging
from 5 (by definition) to 192,978 (with median OTU
size = 15 sequences). Representative sequences from
the 21,247 OTUs matched 728 distinct taxa from 161
genera. Among these, 4,730 (22 %) did not have good
(>100 bp exact match, >97% identity) matches to isolate
sequences from the Ribosomal Database Project (RDP).
These were flagged as ‘unassigned’ in our analysis and are
discussed further below. These sequences are not simply
an artifact of our stringent alignment criteria as evidenced
by the fact that a re-analysis of the 6,879 most abundant
OTUs using the reference-based OTU picking algorithm
implemented in Qiime [7] failed to classify a similar pro-
portion of sequences (2,162 or 31% of the abundant
OTUs).
Microbiota variations by age
The well documented [8-10] succession of the intestinal
microbiota during child development is apparent in our
non-diarrheal control samples (Figure 1A). During the
first year of life, the ‘healthy’ gut microbiota in our infant
cohorts is characterized by comparatively low overall di-
versity and a relatively high proportion of facultatively
anaerobic, and potentially pathogenic, organisms (for ex-
ample, the Escherichia/Shigella group, which cannot be
distinguished from each other by 16S rRNA gene se-
quences), organisms that are believed to play a role in
the development of the host immune system [11,12]. In
older ages, the dominance of these organisms is reduced,
replaced by a corresponding increase in overall diversity
(Figure 1B), accompanied by a particularly pronounced
increase in the proportional abundance of the bacterial
Table 1 Demographics of the children
Demographic characteristics for samples (N = 992), N (%)
MSD
N = 508
Controls
N = 484 P value
Total
N = 992
Age groups by months 0.1788
0 to 5 58 (11) 54 (11) 112 (11)
6 to 11 171 (34) 137 (28) 308 (31)
12 to 17 93 (18) 80 (17) 173 (17)
18 to 23 70 (14) 76 (16) 146 (15)
24 to 59 116 (23) 137 (28) 253 (26)
Country 0.3622
The Gambia 138 (27) 131 (27) 269 (27)
Mali 110 (22) 102 (21) 212 (21)
Kenya 165 (32) 140 (29) 305 (31)
Bangladesh 95 (19) 111(23) 206 (21)
Gender 0.5785
Male 286 (56) 264 (54) 550 (55)
Female 222 (44) 220 (46) 442 (45)
Dysenteric stools
140 (28) 7 (1) <10-16 147 (15)
All ages are in months. P values test independence of MSD cases and controls
with regards to demographic variable. P values for age in months (treated as a
continuous variable) computed by independent samples t-test. P values for
categorical variables calculated using chi-square test.
MSD: Moderate-to-severe diarrhea.
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genus Prevotella. These changes are most evident in our
non-diarrheal control samples, where the genus Prevo-
tella increases from approximately 12% to approximately
48% proportional abundance during the first 5 years of
life, while the Escherichia genus drops from about 20%
proportional abundance in infants under 6 months of
age to approximately 1% in 2- to 5-year-olds (Additional
file 1: Table S1). Two other genera,Veillonella and Strep-
tococcus also exhibit significant decreases with increas-
ing age. Our data also show an increase with increasing
age in the proportion of a range of organisms (labeled
‘unassigned’ in Figure 1A and Additional file 1: Table S1)
that have no good quality matches to cultured isolates in
public databases, and which appear to belong predomi-
nantly to obligate anaerobic bacteria (over 60% can be
assigned by the RDP classifier to the Ruminococcaceae
and Lachnospiraceae families of the Firmicutes phylum,
which are relatively poorly represented in culture collec-
tions [13], as well as the Bacteroidaceae family). These
previously-uncultured putative obligate anaerobes in-
crease in proportional abundance from approximately
8% in diarrhea-free young children to approximately
Figure 1 Comparison of diarrheal and non-diarrheal stool. (A) Proportional abundance of genera in non-diarrheal controls and MSD cases in
different age categories. Each color represents a different group. The order and color for each group is the same for controls (patients without
MSD) and MSD cases. The eight groups most frequently found in controls (Prevotella, Bacteroides, Escherichia/Shigella, Veillonella, Streptococcus,
Lactobacillus, Faecalibacterium, Megasphaera, plus unassigned and other) are depicted. (B) Shannon diversity index across ages and diarrheal
status. Average Shannon diversity indices for the five different age strata as well as the corresponding 95% confidence intervals. Both cases and
controls exhibited higher mean Shannon diversity index scores at higher age groups compared to lower age groups (P <0.001, one-way ANOVA).
The diversity of healthy samples positively correlates with age in the first 2 years of life, as previously reported [12]. The diversity index for cases is
significantly less than that for controls within each country (P <0.02, Tukey’s t-test corrected for multiple comparisons). Also see Additional file 2:
Table S2 and Additional file 3: Figure S1.
Pop et al. Genome Biology 2014, 15:R76 Page 3 of 12
http://genomebiology.com/2014/15/6/R76
23% in the older age group, consistent with increase in
diversity within the intestinal microbiota and the known
expansion of these groups, which are able to colonize
the intestine in greater numbers as the complex poly-
saccharides they utilize for growth become a greater
feature of the host diet [14].
These observations broadly hold when stratifying by
country of origin; however, country-specific effects are
also apparent. For example, the samples from Bangladesh
are different from the African countries, particularly in
the younger age groups, and are characterized by a lower
proportion of Prevotella sequences and a higher propor-
tion of organisms from the Escherichia/Shigella and Strep-
tococcus genera (Figure 1A and Additional file 1: Table S1).
The patterns observed within control samples were
significantly different from patterns from patients with
MSD; however, some overall age-related trends were
similar. For example, Prevotella abundance correlates
with age, albeit reaching a much lower peak, with only
23% abundance in the oldest age group (vs. 48% in con-
trols, P <10-16). Other obligate anaerobic microbes have
lower proportional abundance among cases compared
to controls: Bacteroides and the unclassified putative
anaerobes are both 5% lower in cases, consistent with
previous observations that indicate intestinal dysbiosis is
associated with a decrease in the proportional abun-
dance of obligate anaerobes [15]. Among cases, Escheri-
chia/Shigella and Streptococcus spp. maintain a high
proportion across all age groups, though their prepon-
derance drops significantly (41% to 13% and 18.5% to
7.5%, respectively) as children age. Furthermore it ap-
pears that Prevotella and Escherichia/Shigella are ne-
gatively correlated in MSD cases (Spearman rho = -0.55,
P <0.0001). The disruption associated with diarrhea is
also reflected in lower diversity values in MSD cases in
every age group (Figure 1B, Additional file 2: Table S2,
Additional file 3: Figures S1A-D).
Country-specific effects were also observed in diar-
rheal stool; for instance, in Kenya, diarrhea appeared to
have a less marked effect on the microbiota (Figure 1A
and Additional file 1: Table S1). Escherichia/Shigella spp.
were most common in Mali, accounting for 34% of the
sequences, next most common in Bangladesh (24%) and
least common in The Gambia (15%). Prevotella spp.
were found in high proportional abundances in The
Gambia (18%) and Kenya (19%). The genus Streptococ-
cus is found in relatively high abundances in Bangladesh
(21%) and The Gambia (13%) with lower abundances in
Mali (10%) and Kenya (9%). As expected, the taxonomic
diversity (Shannon diversity index) is significantly differ-
ent between cases and controls in all countries (P <0.005,
pairwise t-test). Of note, where Prevotella is more com-
mon (The Gambia and Kenya), the diversity is higher
(Figure 1B).
Taxonomic groups statistically increased or decreased in
diarrhea
Multidimensional scaling analysis could not separate
the diarrhea and diarrhea-free bacterial communities
due to high inter-personal variation (Additional file 3:
Figure S3). We estimated the association of individual
OTUs with disease using statistical tests addressing
both presence-absence statistics (Fisher’s exact test and
logistic regression) and abundance-dependent statistics
(using generalized linear models) that account for the
number of OTU-specific sequences in each stool, and
potential confounders such as sampling depth, age, and
country (see Additional file 4: Table S3 for a full sum-
mary). The former address similar questions to those
commonly targeted by the traditional culture-based epi-
demiological studies, while the latter allow us to assess
how pathogen proportional abundance correlates with
morbidity.
Ten OTUs were found to be positively associated with
diarrhea by all statistical tests. The OTUs associated
with MSD have high-similarity matches against database
sequences from bacterial taxa in the Escherichia/Shigella,
Granulicatella spp., and Streptococcus mitis/pneumoniae
groups. When only abundance-dependent statistics are
used to determine significance, an additional 18 OTUs are
found to be highly associated with diarrhea, corresponding
to the bacterial species Escherichia/Shigella, Campylo-
bacter jejuni, and Streptococcus pasteurianus. When only
considering presence/absence statistics, 43 additional
OTUs are found to be associated with diarrhea, com-
prising the bacterial groups already discussed above
as well as members of the genera Lactobacillus, Neisseria,
Citrobacter, Erwinia, and Haemophilus. It is noteworthy
that all of these organisms are either facultatively anaer-
obic or microaerophilic.
On the other hand, there were no OTUs positively as-
sociated with healthy stools by both statistical methods,
reflecting the higher degree of inter-individual variation
in microbiota content in healthy individuals. Consi-
dering only presence/absence statistics, there are 43
OTUs associated with non-diarrheal control samples.
The genera associated with these control samples in-
clude members of the clostridial families Peptostrepto-
coccaceae, Eubacteriaceae, and Erysipelotrichaceae, and
the genera Clostridium sensu stricto, Dialister, Entero-
coccus, Prevotella, Ruminococcus, and Turicibacter. When
considering only abundance statistics, an additional 19
OTUs are significantly associated with non-diarrhea sam-
ples and have high quality matches to database sequences
corresponding to Bacteroides fragilis, Dialister, Mega-
sphaera, Mitsuokella/Selenomonas, Prevotella spp., and
Clostridium difficile. Thus, it can be seen that many obli-
gate anaerobic bacterial lineages correlate with healthy
status.
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Functional differences between cases and controls
The broad statements made above about oxygen tolerance
in the diseased microbiota are supported by PICRUST
[16] analyses of our data. Specifically, this showed putative
signatures of obligate anaerobic gut lineages to be en-
riched in the diarrhea-free samples (for example, glycoly-
sis, P = 10-9; pyruvate metabolism, P = 10-7; short chain
fatty acid biosynthesis, P = 10-3; xylene degradation, P =
10-7; and so on; all P values by Welch’s t-test as computed
by STAMP [17]), while oxygen dependent pathways (for
example, the TCA cycle, P <10-15) are enriched in diseased
samples.
Taxonomic groups correlated with dysentery
We segregated diarrheal stool based on diagnosis of dys-
entery (presence of blood) and found a total of 30 OTUs
that were strongly correlated with dysentery when com-
paring with non-dysentery diarrheal stool (metageno-
meSeq [18], P <0.05). These include several well-known
pathogens such as Enterococcus faecalis, Campylobacter
jejuni, Bacteroides fragilis, Clostridium perfringens, En-
terobacter cancerogenus, and members of the Granulica-
tella, Haemophilus, Klebsiella, and Escherichia/Shigella
genera. Also associated with dysentery were members of
the Streptococcus pasteurianus and Streptococcus sali-
varius groups. A single OTU, corresponding to Lacto-
bacillus ruminis, was found to be negatively associated
with dysentery. A genus-level representation of these
findings is shown in Figure 2.
Network view of diarrheal illness
The overall results presented above are also borne out
in correlation networks constructed from the data
(Additional file 3: Figure S7). At the broad level, in both
MSD cases and controls, it can be seen that there tend to
be negative correlations between facultative anaerobic lin-
eages and obligate anaerobic lineages. The most obvious
example is the negative correlation of the potentially pro-
tective Prevotella genus with that of potential pathogens
such as Escherichia/Shigella. Similarly, there are also
positive correlations within these two phenotypic sub-
groupings, such that obligate anaerobic genera such as
Prevotella, Roseburia, and Dialister are correlated with
each other, while facultative anaerobic or microaerophilic
genera such as Streptococcus, Lactobacillus, Escherichia/
Shigella, and other Proteobacteria are also correlated with
each other. The diarrhea-free network appears to be more
tightly connected than the diarrheal network, consistent
with ecological theories that equate environment diversity
and connectedness with ecosystem stability/health [19,20].
At the same time, we would like to note that our data do
not allow a reliable quantitative assessment of such phe-
nomena due to the large level of inter-personal variation.
Discussion
Our analysis of the 16S rRNA gene-based taxonomic
profile of diarrheal and control stool samples has dem-
onstrated a strong association between acute diarrheal
disease and the overall taxonomic composition of the
stool microbiota in young children from the developing
world. We have identified statistically significant disease
associations with several organisms already implicated in
diarrheal disease, such as members of the Escherichia/
Shigella genus and C. jejuni. In addition, we have un-
covered an association with diarrheal disease for several
organisms not widely believed to cause this disease, such
as Streptococcus and Granulicatella. Streptococcal OTUs
associated with disease primarily belong to either the
Streptococcus pneumoniae/mitis group (indistinguishable
within the 16S rRNA gene regions targeted by our study),
which contains several important human pathogens, or
the Streptococcus pasteurianus group. These results merit
further exploration as recent studies provide evidence of
Streptococcus-related diarrheal cases [21,22]. It is import-
ant to stress that pathogenicity is only one of many pos-
sible explanations for these findings and the organisms
associated with disease status may also either: (1) usually
inhabit the upper GI tract and become apparent in diar-
rheal stool due to dislodging and reduced transit time dur-
ing disease; (2) thrive in disturbed gut environments; (3)
may be better able to persist/resist dislodgement during a
diarrheal purge; or (4) a combination of pathogens may
cause disease in these children [23]. Prior evidence cer-
tainly suggests that facultative anaerobes (many of which
we find associated with diarrhea) tend to flourish in a var-
iety of perturbed gut environments, possibly because the
reducing power of the microbiota is affected by the loss of
obligate anaerobes following perturbation [15]. Any caus-
ality would need to be demonstrated through further ex-
perimentation. At the same time, streptococci are also
found in our study to be associated with more severe
forms of diarrhea (dysentery), thereby strengthening the
case for a possible causal connection. Despite uncertainty
regarding the causes and effects of microbiota pertur-
bations in the setting of MSD, dissecting the physiologic
implications is warranted. For example, an increase in
streptococcal or other species in the setting of diarrhea
may confer or exacerbate diarrheal effects. S. mutans has
recently been postulated to have a role in human enteritis.
Our work represents an important first step in under-
standing the complex interaction between microbiota and
diarrheal pathogens in developing country settings.
Our study has also revealed a high prevalence of mem-
bers of the Prevotella genus (primarily Prevotella copri)
in the stool of developing world children, as well as the
negative correlation of this genus with disease. These or-
ganisms are prevalent in the developing world [14], yet
are relatively poorly studied due to fairly low prevalence
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in the industrialized world [24]. Samples containing high
proportions of members of the Prevotella genus also
have higher overall bacterial diversity, potentially driven
by the level of complex polysaccharides/starchy fiber in
the diet. Recent evidence suggests that Prevotella spp.
are particularly abundant in rural African children con-
suming a high fiber diet [25]. This is in stark contrast to
Western children, who typically have much higher abun-
dances of Bacteroides spp., and very little Prevotella, a
difference that is believed to be linked to diet [26].
Figure 2 Comparison of dysenteric and non-dysenteric stool. (A) Genus-level comparison of dysenteric and non-dysenteric diarrheal stool
(top) stratified by age; (bottom) stratified by country. (B) Proportional abundance boxplots of Prevotella, Lactobacillus, and Streptococcus in
dysenteric and non-dysenteric diarrheal stools by age category. The upper whisker extends from the 75th percentile to the highest value that is
within 1.5 * IQR of the hinge, where IQR is the inter-quartile range, or distance between the first and third quartiles. The lower whisker extends
from the hinge to the lowest value within 1.5 * IQR of the hinge. Data beyond the end of the whiskers are outliers and are not plotted. Asterisks
above the whisker indicate a statistically significant difference (by t-test) between dysenteric and non-dysenteric stools placed in the panel with
the more abundant mean. A single asterisk indicates P <0.05; double asterisks indicate P <0.01. Prevotella is significantly associated with
non-dysenteric cases overall (P = 0.0003) and in age groups 0 to 6 months (P = 0.01), 12 to 17 months (P = 0.03), and 24 to 59 months (P = 0.001).
Lactobacillus is significantly associated with non-dysenteric cases overall (P = 0.0002) and in children 6 to 11 months (0.02) and 12 to 17 months
(P = 0.003), while the genus Streptococcus is associated with dysentery overall (P = 0.007), particularly in children aged 12 to 17 months (P = 0.01).
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Our co-occurrence network analyses (Additional file 3:
Figure S7) and proportional abundance analysis (Additional
file 1: Table S1) suggest potential negative interactions
between Prevotella and enteric pathogens, such as mem-
bers of the Escherichia/Shigella genus, raising the pos-
sibility for the development of novel Prevotella-based
therapeutic strategies. Another possible probiotic organ-
ism identified in our study is Lactobacillus ruminis. This
organism was found to be associated with non-diarrheal
stool and also with less severe forms of diarrhea when
comparing diarrheal to dysenteric stool. Although the in-
crease in frequency of these taxa in diarrhea could be due
to shortened intestinal transit time, the difference in pre-
valence of Lactobacillus between cases of MSD and dysen-
tery are less likely to represent this effect. Lactobacillus
ruminis has immunomodulatory properties and has been
previously suggested as a potential probiotic [27].
Among OTUs found associated with non-diarrheal
stool are sequences classified as Clostridum difficile, a
surprising finding given that this organism is a common
cause of enteric disease, primarily in hospitalized elderly
patients. However, although C. difficile can be an impor-
tant pathogen, it is actually carried asymptomatically by
around 60% of infants [28]. We also found a conflicting
association of OTUs assigned as Bacteroides fragilis with
both the diarrhea-free status and dysentery, a finding
that can perhaps be explained by strain-to-strain var-
iation. Enterotoxigenic B. fragilis strains are well cha-
racterized diarrheal agents in children [29] whereas, in
contrast, non-toxigenic B. fragilis has been linked to
anti-inflammatory protective effects in mouse models
[30]. It is therefore possible that different strains, which
cannot be differentiated through 16S rRNA gene se-
quencing, might account for these opposing results.
Our study identified many sequences that do not have
good matches against cultured organisms in current 16S
rRNA gene databases. Many of these sequences only have
high-quality matches to other uncultivated and uncharac-
terized intestinal microbes, highlighting the presence of a
large reservoir of uncharacterized microbes in the in-
testinal tract of children within the developing world, as
reported before [31]. Many of the unknown sequences ap-
pear to belong to obligate anaerobic lineages of the Firmi-
cutes phylum, which are under-represented in culture
collections compared to other intestinal dwelling groups
such as Bacteroides and bifidobacteria. The prevalence of
such ‘unknown’ sequences is higher in controls and several
of these uncharacterized organisms exhibit strong associa-
tions with diarrhea-free samples, highlighting their poten-
tial role in the maintenance of a healthy gut microbiota,
and suggesting the need for a better in-depth characte-
rization of the gut microbiota of children within the devel-
oping world, complementing resources recently developed
in Europe [32] and the US [33].
Our observations related to the microbial succession
in the developing infant gut microbiota carry several ca-
veats. A single sample was collected from each child at a
single point in time, and we lack extensive data on prior
history of diarrhea. While the data are suggestive of a
progression in microbiota structure, monitoring of a
birth cohort will be necessary to fully understand the
progression of gut microbiota, and assess the impact of
diarrhea (including, potentially, multiple episodes of
diarrhea) on this process. At a technical level, we would
also note that the primer sets used in this study (target-
ing the V1-V2 hypervariable regions of the 16S rRNA
gene) do not effectively amplify bifidobacteria [34,35],
known to be dominant members of the intestinal micro-
biota of breast-fed infants, but this bias is likely to be
uniform between cases and controls. We purposefully
selected a primer set better targeted towards bacterial
groups containing known and potential pathogens, such
as Enterobacteriaceae, to improve our chances of detect-
ing novel pathogens at the cost of obtaining less informa-
tion about the already well-established early dominance
by bifidobacteria.
Our study revealed the limitations of existing molecu-
lar and bioinformatics approaches employed in a clinical
setting for performing taxonomic surveys of stool sam-
ples. The use of the 16S rRNA gene, for example, does
not afford a sufficient discrimination within taxonomic
groups containing known or putative pathogens (Escher-
ichia/Shigella, Streptococcus, and so on) indicating the
pressing need for the development of new cost-effective
and relatively unbiased molecular approaches [36] for in-
creasing the resolution of epidemiological surveys such
as ours. Relatedly, the accurate taxonomic assignment of
sequences generated in studies such as ours is hampered
by numerous errors in public databases and by the use
of simplistic ‘lowest common ancestor’ heuristics by soft-
ware tools faced with ambiguous taxonomic information.
The results presented in this paper were obtained through
the careful manual annotation of all the OTUs found
to be associated with disease state (see Additional file 5:
Table S4). Finally, we had to develop a novel statistical
method [18] for identifying disease association in order to
appropriately address data rarefaction as well as to control
for the high inter-personal variability, a typical feature of
the healthy gut microbiota [37], and other confounding
factors.
Conclusions
Overall our study demonstrates that the major differ-
ences in the microbiota between diarrheal and normal
stools are quantitative differences in the proportions of
the most prevalent taxa. Such quantitative differences
were also observed in our previous qPCR-based study
where we found that 80% (1,665/2,072) of controls and
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89% (1,307/1,461) of MSD cases had detectable levels of
Shigella. Quantitative measurements of Shigella abun-
dance were critical to assessing attributable risk [38].
Among the known causes of diarrhea (rotavirus, Shigella,
Cryptosporidium, Enterotoxigenic E. coli, and so on) the
attributable fraction of diarrhea in young children is esti-
mated to be just 43% [5]. Our study provides initial evi-
dence for the existence of novel pathogenic agents. The
most likely candidates from our study are members of the
Enterobacteriaceae and streptococci, taxa which already
contain many known human pathogens. Further explor-
ation of these organisms is necessary to better understand
their pathogenic potential and the likelihood of their
emergence as major pathogens through the acquisition of
additional pathogenicity factors. Importantly, our study re-
veals a possible protective role against diarrhea for the
Prevotella genus and Lactobacillus ruminis. Understand-
ing such effect is important. For example, microbiological
[39] or dietary [26] interventions may be possible in the
supportive treatment of diarrhea in children similar to ap-
proaches used in the management of enteric infections
in adults [39-41]. Further genomic and epidemiologi-
cal studies are necessary to better characterize this ge-
nus and to assess the potential development of diet- or
microbiological-based therapeutics.
Materials and methods
Study design and participants
Stool samples were selected from a large case/control
study of moderate-to-severe diarrhea in children aged
under 5 years [42]. Cases were enrolled upon presenta-
tion to a health clinic reporting MSD. MSD eligibility
criteria included sunken eyes, loss of normal skin turgor,
a decision to initiate intravenous hydration or to hos-
pitalize the child, or the presence of blood in the stool.
Controls were sought following case enrollment, sam-
pled from a demographic surveillance database of the
area. Individuals were excluded if they were unable to
produce a sufficient amount of stool volume for testing
or they were unable or unwilling to consent to involve-
ment in the study. Every participant was consented prior
to collection of their stool and their data. Consent was
given by the caregiver (usually mother) because the pa-
tients are all children aged less than 5 years. All samples
were collected between March of 2008 and June of 2009.
One sample was collected for each child and no time-
series analyses were conducted. The Institutional Review
Boards (IRBs) at all cooperating institutions have reviewed
and approved the protocol. The IRB Federal Wide Assur-
ance numbers for all the sites are as follows: University of
Maryland Baltimore FWA00007145, The Gambia, Medical
Research Council Labs FWA 00006873, Kenya Medical
Research Institute FWA 00002066, University of Mali Fac-
ulty of Medicine Pharmacy and Dentistry FWA 00001769,
and International Centre for Diarrhoeal Disease Research,
Bangladesh FWA 00001468. Further details on study de-
sign are described by Kotloff et al. [42].
Microbiology methods
Stool specimens were collected in sterile containers and
examined within 24 h. Stools were stored at 2 to 8°C
while in transit to the laboratory. Each fresh stool speci-
men was aliquoted into multiple tubes. All samples were
analyzed by traditional microbiological tests for known
bacterial, viral, and eukaryotic pathogens. Details of
these methods can be found in Panchalingam et al. [43]
DNA was isolated using a bead beater with 3 mm diam-
eter solid glass beads (sigma Life Science), and subse-
quently 0.1 mm zirconium beads (BIO-SPEC Inc.) to
disrupt cells. The cell slurry was then centrifuged at
16,000 g for 1 min, the supernatant removed and proc-
essed using the Qiagen QIAamp® DNA stool extraction
kit. Extracted DNA was precipitated with 3 M sodium
acetate and ethanol and the DNA shipped to the USA.
Amplification and sequencing
DNA was amplified using ‘universal’ primers targeting
the V1-V2 region of the 16S rRNA gene (small subunit
of the ribosome) in bacteria (338R (5’- CATGCTGCC
TCCCGTAGGAGT-3’ and 27 F (5’-AGAGTTTGATC
CTGGCTCAG-3’). Both forward and reverse primers
had a 5’ portion specific for use with 454 FLX sequen-
cing technology and the forward primers contained a
barcode between the FLX and gene specific region, so
that samples could be pooled to a multiplex level of 96
samples per instrument run (see Additional file 6: Table S5
for barcode information).
Data availability
Sequencing data and sample metadata are available at
the NCBI archive under project PRJNA234437.
Source code and documentation for the analysis pipe-
line are available at GitHub: [44].
Abundance table and metadata are available, in BIOM
[45] format, at [46].
Additional information on the study as well as links to
all resources outlined above are made available at [47].
Analysis pipeline
The individual reads were filtered for quality using cus-
tom in-house scripts that perform the following checks
suggested in Huse et al. [48]: (1) sequences containing
any ambiguity codes (N) are removed; (2) sequences that
were shorter than 75 cycles of the 454 instrument were
removed (each cycle yields an average of 2.5 bp depen-
ding on the sequence composition); (3) sequences for
which a barcode could not be identified were removed.
These checks are similar to those that can be performed
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by Mothur [49]. The high quality sequences were sepa-
rated into 992 sample-specific sets according to the mul-
tiplexing barcodes. Conservative OTUs were clustered
using DNAclust [6] with parameters (-r 1) (99% identity
radius) thus ensuring that the definition of an OTU is
consistent across all samples. To obtain taxonomic iden-
tification, a representative sequence from each OTU was
aligned to Ribosomal Database (RDP) [50] (rdp.cme.
msu.edu, release 10.4) using blastn with long word
length (-W 100) in order to only detect nearly identical
sequences. Sequences without a nearly identical match
to RDP (>100 bp perfect match and >97% identity, as
defined by BLAST) were marked as being ‘unassigned’
and assigned an OTU identifier. The resulting data were
organized into a collection of tables at several taxo-
nomic levels containing each taxonomic group as a row
and each sample as a column.
We note that the clustering criteria we use (<2% diver-
gence, including insertions and deletions) are more con-
servative than commonly used definitions of ‘species-
level’ OTUs (<2% divergence excluding indels). We used
conservative clustering because no universal cutoff ap-
plies to all organisms [51] and in order to avoid merging
together organisms with potentially different phenotypes
(for example, closely-related strains, see Additional file 3:
Figure S4 for an example in closely-related Escherichia/
Shigella OTUs). Similar considerations have led to the
development of specialized software for the analysis of va-
ginal 16S rRNA gene survey data [52]. Our approach pro-
vides a good tradeoff between mitigating the effect of
errors and allowing an unbiased analysis of the data. Fur-
thermore, an exploration of increasingly permissive clus-
tering thresholds reveals that our conservative clustering
strategy does not lose statistical power (see Additional file 3:
Figures S5, S6).
Chimera checking was performed with Uchime 4.2.40
[53].
PICRUST analysis
The most abundant 6879 OTUs were reprocessed using
QIIME [7] version 1.8.0-dev as recommended on the
PICRUST website (specifically OTUs were constructed
with the pick_closed_reference_otus.py script against the
latest version (version 13.5) of the Greengenes [54] data-
base) and the resulting information was processed with
PICRUST [16] version 1.0.0-dev using the KEGG ana-
lysis module and aggregating the results to level 3. The
results were further explored with STAMP [17] version
2.0.2, using the two-group analysis module, focusing on
known aerobic and anaerobic pathways.
Data normalization
In order to avoid the bias that may be introduced by pref-
erential amplification or sequencing of specific sequences,
we scaled the counts by the 56th percentile of the number
of OTUs in each sample. The 56th percentile was empiric-
ally determined from the distribution of non-zero counts
required to behave consistently across our samples. We
normalized with a Cumulative Sum Scaling approach,
which scales counts by dividing the sum of each sample’s
counts up to and including the pth quantile (that is, for all
samples j, Sp = ∑ i(cij|cij) ≤ qpj, where qpj is the p
th quantile
of sample j). Normalized counts are then given by cijSpj 1000.
This method constrains communities with respect to a
total size, but does not place undue influence on features
(OTUs) that are preferentially sampled. A full description
of the methodology is provided in Paulson et al. [18].
Statistical approaches
To test for presence and absence of an organism we per-
formed Fisher’s test stratifying by positive and negative
samples. Samples were stratified as positive for an organ-
ism if the sample had one or more sequences of the or-
ganism with a sample being negative if there was absence
of sequences. The totals were calculated for each taxa, a
minimum of 20 positive samples was required for a sta-
tistical test to be attempted. To correct for multiple com-
parisons we minimized the expected proportion of false
positives following Benjamini and Hochberg [55].
Differential abundance was assessed with the package
metagenomeSeq [18] - a statistical approach that models
confounding such as age and country, and also the effect
of undersampling on the observed counts. Significant
findings were reported for OTUs that satisfied the fol-
lowing criteria: (1) OTU was abundant (≥12 normalized
counts per sample) in cases or controls; (2) OTU was
prevalent (present in ≥10 cases and controls); (3) OTU
had fold change or odds ratio exceeding 2 in either cases
or controls; and (4) statistical association was significant
(P <0.05) after Benjamini-Hochberg correction for mul-
tiple testing.
Analyses were performed using the R software package
3.0.1 and packages, Vegan 2.0-7 and metagenomeSeq
1.2.21.
Correlation network construction
Correlation networks were constructed separately on
cases and controls to characterize the dependencies bet-
ween 268 differentially abundant OTUs (Additional file 4:
Table S3).
Each network was built using SparCC [56], a tool spe-
cifically developed for assessing the correlation structure
within microbial communities. The statistical significance
for each OTU-OTU-interaction was obtained with an em-
pirical null distribution using 1,000 bootstrap iterations.
The P values were further adjusted for multiple compari-
sons using the Benjamini and Hochberg [55] correction.
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All OTU-OTU-interactions with FDR < =0.05, were con-
sidered significant and were represented as edges in the
network.
For simplicity of visual representation, OTUs were ag-
gregated at genus or lower taxonomic levels using the
median normalized abundance of the aggregated OTUs
as the abundance of the corresponding taxonomic group.
We omitted all taxonomic groups with median abundance
lower than 500 normalized counts, as well as all edges
with SparCC correlation lower than 0.09. The plots were
drawn in Cytoscape 3.0.1 [57].
Additional files
Additional file 1: Table S1. Proportional abundance of dominant
bacterial genera in cases and controls, both overall and stratified by age
stratum and country.
Additional file 2: Table S2. Comparison of Shannon diversity across
ages and countries. P-values computed with Tukey’s honestly significant
difference test to account for multiple comparisons.
Additional file 3: Additional figures (S1-S8) and figure captions.
Additional file 4: Table S3. OTUs found to be significantly associated
with diarrhea or with diarrhea free controls.
Additional file 5: Table S4. Mapping of taxonomic names used in
our paper and nearest hits to the corresponding 16S rRNA sequence.
Due to the poor resolution of the 16S rRNA region used in our study we
manually assigned each OTU to the most precise taxonomic level
possible. In some cases a same organism appears in multiple groups,
reflecting errors in the underlying database used (RDP version 10.4). For
brevity, only ambiguous taxonomic groups are listed.
Additional file 6: Table S5. Mapping of barcode information to
sample IDs.
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